Home > products > apis > autophagy > cc214-2

CC214-2 CAS No.1228012-18-7

Catalog #	Pkg Size	Price(USD)	Quantity	Buy this product
R-R-2173	5mg	380.00	- +	+ Add to cart
R-R-2173	10mg	660.00	- +	+ Add to cart

Product description

CC214-2/CAS No.1228012-18-7 is an oral active and selective mTOR kinase inhibitor. CC214-2 targets to both of mTORC1 (pS6) and mTORC2 (pAktS473). CC214-2 induces autophagy, which is a potential target for host-directed therapy (HDT) in tuberculosis. CC214-2 exhibits synergistic bactericidal and sterilizing activity agasinst tuberculosis (TB), and shortens the treatment duration. CC214-2 also inhibits Rapamycin (HY-10219)-resistant signaling and the growth of glioblastomas in vitro and in vivo.

Appearance	N/A
Molecular Weight	383.44
Purity	>90%
CAS	1228012-18-7
Formula	C20H25N5O3
Storage	-20℃, protected from light and moisture
Transportation	4-25℃ temperature for up to 2 weeks
Stability	1 year

Document

msds of CC214-2 CAS No.1228012-18-7